Autophagy : Moving Benchside Promises to Patient Bedsides

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|8|684-702

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.8, 2015-01, pp. : 684-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell-Based Therapies in the Bench and the Bedsides

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 305-310

Bentham Science Publishers

Access to resources Recommend Favorite

Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2825-2840

Bentham Science Publishers

Access to resources Recommend Favorite

Bioavailability of Quercetin: Problems and Promises

By  

Current Medicinal Chemistry, Vol. 20, Iss. 20, 2013-07 ,pp. : 2572-2582

Bentham Science Publishers

Access to resources Recommend Favorite